Thomas Martin, MD
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma (NCT07340853) | Thomas Martin, MD | 2026-02-28 |
| Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma (NCT05577000) | Thomas Martin, MD | 2021-10-18 |
Track Thomas Martin, MD automatically
Every clearance here is in the API, with alerts when new ones post.